US based SZL looks similar to the previous names although a lot less volatile than APT & Z1P. We like SZL into fresh 2021 lows which again cannot be ruled out in this volatile sector.
scroll
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
Friday 6th June – Dow off -108pts, SPI down -13pts
Close
MM likes SZL under $6
Add To Hit List
Relevant suggested news and content from the site

Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.


chart
Eli Lilly & Co (LLY US) v Novo Nordisk (NVO US)

Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.

Podcast
LISTEN
Friday 6th June – Dow off -108pts, SPI down -13pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.